1. Home
  2. HERE vs CRBU Comparison

HERE vs CRBU Comparison

Compare HERE & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HERE

Here Group Limited American Depositary Shares

N/A

Current Price

$3.53

Market Cap

193.1M

Sector

Real Estate

ML Signal

N/A

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

HOLD

Current Price

$1.95

Market Cap

179.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HERE
CRBU
Founded
2019
2011
Country
China
United States
Employees
714
N/A
Industry
Other Consumer Services
Medicinal Chemicals and Botanical Products
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
193.1M
179.7M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
HERE
CRBU
Price
$3.53
$1.95
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$10.75
AVG Volume (30 Days)
75.9K
1.3M
Earning Date
06-05-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
3.64
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$1.63
Revenue Next Year
$79.29
$10.93
P/E Ratio
$2.83
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.89
$0.73
52 Week High
$5.80
$3.53

Technical Indicators

Market Signals
Indicator
HERE
CRBU
Relative Strength Index (RSI) 47.71 46.13
Support Level $2.94 $1.70
Resistance Level $3.75 $2.06
Average True Range (ATR) 0.14 0.12
MACD 0.02 -0.04
Stochastic Oscillator 35.14 20.54

Price Performance

Historical Comparison
HERE
CRBU

About HERE Here Group Limited American Depositary Shares

Here Group Ltd is dedicated to creating collectible pop toys that evoke joy and emotional resonance. The group design and compelling storytelling, which provide users with a collecting experience that blends artistic value with emotional warmth, continuously convey a joyful and immersive brand culture. Adhering to the brand philosophy of joy, integrity, wonder, and co-creation, the company is building a vibrant ecosystem connecting creativity and emotion, working hand-in-hand with overall toy enthusiasts to create, share, and transmit dreams.

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.

Share on Social Networks: